SLC25A6
ADP/ATP translocase 3
Also known as: ADT3_HUMAN, ANT3, ANT3Y, MGC17525
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P12236
- Gene
- SLC25A6
- Ensembl
- ENSG00000169100
- Chromosome
- X
- Canonical length
- 298 aa
- Protein class
- FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene is a member of the mitochondrial carrier subfamily of solute carrier protein genes. The product of this gene functions as a gated pore that translocates ADP from the cytoplasm into the mitochondrial matrix and ATP from the mitochondrial matrix into the cytoplasm. The protein is implicated in the function of the permability transition pore complex (PTPC), which regulates the release of mitochondrial products that induce apoptosis. The human genome contains several non-transcribed pseudogenes of this gene. [provided by RefSeq, Jun 2013]
Canonical amino-acid sequenceUniProt
298 residues, UniProt reviewed canonical sequence.
>P12236|SLC25A6
1 MTEQAISFAK DFLAGGIAAA ISKTAVAPIE RVKLLLQVQH ASKQIAADKQ YKGIVDCIVR
61 IPKEQGVLSF WRGNLANVIR YFPTQALNFA FKDKYKQIFL GGVDKHTQFW RYFAGNLASG
121 GAAGATSLCF VYPLDFARTR LAADVGKSGT EREFRGLGDC LVKITKSDGI RGLYQGFSVS
181 VQGIIIYRAA YFGVYDTAKG MLPDPKNTHI VVSWMIAQTV TAVAGVVSYP FDTVRRRMMM
241 QSGRKGADIM YTGTVDCWRK IFRDEGGKAF FKGAWSNVLR GMGGAFVLVL YDELKKVILocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC25A6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 854 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 854 nTPM
- ovary: 666 nTPM
- salivary gland: 658 nTPM
- choroid plexus: 651 nTPM
- kidney: 631 nTPM
- stomach: 596 nTPM
Single-cell type
- decidual stromal cells: 2,369 nCPM
- esophageal basal cells: 1,952 nCPM
- cytotrophoblasts: 1,900 nCPM
- syncytiotrophoblasts: 1,867 nCPM
- migrating cytotrophoblasts: 1,843 nCPM
- enteric stem cells: 1,617 nCPM
Immune cell
- total PBMC: 1,120 nTPM
- myeloid DC: 988 nTPM
- non-classical monocyte: 836 nTPM
- intermediate monocyte: 809 nTPM
- classical monocyte: 740 nTPM
- memory B-cell: 674 nTPM
Brain region
- choroid plexus: 538 nTPM
- cerebral cortex: 301 nTPM
- basal ganglia: 299 nTPM
- thalamus: 280 nTPM
- amygdala: 273 nTPM
- hippocampal formation: 272 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC25A6.
Disease | ImmuneIEDB
Conditions an epitope on SLC25A6 was assayed in.
- skin melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.78
- gnomAD pLI
- 0.14
- gnomAD missense Z
- 0.56
OntologyGO
Biological processes
- apoptotic process
- mitochondrial ADP transmembrane transport
- mitochondrial ATP transmembrane transport
- negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SLC25A6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC25A6 as an antibody target. Whether an autoantibody or antibody against SLC25A6 could matter depends on whether native SLC25A6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC25A6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SLC25A6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...